
Nutrien Ltd. remains a Buy as current market pricing ignores dual catalysts: global LNG disruption and a reversal in the agricultural cycle. NTR's North American nitrogen assets benefit from structura
Nutrien NYSE: NTR reported second-quarter adjusted EBITDA of $2.4 billion and first-half adjusted EBITDA of $3.5 billion, up 6% from a year earlier, as record potash sales volumes, proprietary-product